MZ

Mark Ziirsen

Mr Ziirsen served as non-executive director and chair of Respiri Limited and as non-executive director and chair of the Audit and Risk Committee of Orcoda Limited, a SaaS-based technology company. His executive career includes senior finance leadership roles with major ASX listed companies including Cochlear Limited, Aristocrat Leisure Limited, Coca-Cola Amatil Limited and Goodman Fielder Limited. He commenced his career with EY in business advisory, tax and management consulting. Most recently, he was CFO and company secretary for Nasdaq-listed Cenntro Electric Group. Prior to that he was CFO of ASX listed Wiseway Group Limited and global Medtech company Anteris Technologies Limited and before that, Director of Finance and IT for Asia Pacific at hearing implant maker Cochlear Limited.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/04/24706,776N/A1,400,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
18/01/24
Issued
201,936$0.030$6,058Rights issue
01/12/23
Issued
420,465$0.040$16,818Director remuneration
01/12/23
Issued
300,000$0.040$12,000Employee Share Ownership Plan
15/02/23
Issued
16,875$0.020$337Rights issue
09/02/22
Buy
67,500$0.096$6,480On-market trade